Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new pain drug Journavx
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
2h
What's Happening With VRTX Stock?
With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...
2h
Buy Rating for Vertex Pharmaceuticals: FDA Approval of Journavx Boosts Market Potential and Stock Price Target
Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...
2h
on MSN
Brand-new painkiller approved by US health agency
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Black boxes recovered
Los Angeles wildfire updates
Cause of death revealed
Apologizes for old tweets
Activists call for boycott
Top leaders asked to resign
Inmate's transfer blocked
Asteroid may hit Earth
Sexual misconduct accusation
Michigan priest loses license
Searching for joyriders
Confirmed interior secretary
Ex-worker admits to theft
To raise hourly pay
Hamas confirms death
Olympic gold medalist dies
Recuses self from Act 10 suit
Deputy shooting sentence
2 more victims in indictment
FDA approves painkiller
S3 release date revealed
Ground stop amid IT outage
'As Tears Go By' singer dies
DOJ sues to block deal
Blames DEI for crash
Mountain granted personhood
Ebola outbreak in Uganda
Nashville bids for franchise
Shiffrin finishes 10th
Related topics
Vertex Pharmaceuticals
Pain management
United States
Food and Drug Administration
Feedback